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Results: Of 535 subjects with CE MRI, 453 subjects had complete data
on synovitis and WOMAC pain. Mean age was 59.2±7.2 years, mean
BMI 29.7±5.0, and 48% were women. Moderate/severe synovitis was
uncommon (15% of knees) but of knees with at least moderate pain, 49%
had moderate/severe synovitis with 4.8 times increased odds of knee pain
compared to those without synovitis. Other WOMAC deﬁnitions of pain
severity yielded similar results. Among knees without ROA (n = 297), while
few had moderate/severe synovitis, synovitis itself was still associated
with increased prevalence of pain.
Conclusions: Moderate/severe synovitis has a strong relation with knee
pain severity, an association detected more clearly with CE MRI than
suggested by prior studies using nonCE MRI measures of synovitis.
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473 DIFFERENTIAL PROTEOME OF ARTICULAR
CHONDROCYTES FROM PATIENTS WITH OSTEOARTHRITIS
B. Ferna´ndez-Gutie´rrez1, F. Marco2, E. Camafeita3, E. Calvo3,
L. Lo´pez-Dura´n2, J.A. Jover1, J.A. Lo´pez3, R. Rollı´n2. 1Servicio de
Reumatologı´a. Hospital Clı´nico San Carlos, Madrid, SPAIN, 2Servicio
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Madrid, SPAIN, 3CNIC, Madrid, SPAIN
Purpose: Cartilage damage is a major problem in osteoarthritis (OA). To
gain insight into the pathogenesis of OA, we have analyzed the differential
proteome of articular chondrocytes from these patients.
Methods: Protein extracts were prepared from cultured chondrocytes
from 6 patients with end-stage OA and 6 normal donors without special ra-
diographic signs of OA. Samples were then analyzed by 2D gels using the
DIGE approach. Gel image analysis was performed using the DeCyder
Differential Analysis Software Release 6.5 and statistical module EDA 1.0
(GE Healthcare). Protein spots corresponding to statistically signiﬁcant
expression differences were excised from the gels and submitted to
tryptic digestion, and the resulting peptides were mass analyzed using an
Ultraﬂex MALDI-TOF/TOF mass spectrometer (Bruker-Daltonics). Protein
identiﬁcation was achieved through database searching with MALDI MS
and MS/MS data.
Results: Signiﬁcant differential expression was observed for 27 proteins,
with 14 underexpressed and 13 overexpressed chondrocyte OA proteins.
Of special interest was the identiﬁcation of destrin, coﬁlins, gelsolin,
annexin A2, glycolytic enzymes, chaperones, cathepsin D, proteasome
beta 9 subunit isoform 2 proprotein and proteasome activator hPA28.
Conclusions: The altered expression of these proteins is consistent
with events such as cytoskeleton binding protein disruption, apoptosis,
and glycolysis, demonstrating the ability of the 2D-DIGE/MS platform to
identify proteins with altered expression in chondrocytes from patients
with end-stage OA. The identiﬁcation of these proteins may open new
lines of research for this disease.
474 A ROBUST METHOD FOR PROTEOMIC CHARACTERIZATION
OF MOUSE CARTILAGE USING SOLUBILITY-BASED
FRACTIONATION AND TWO-DIMENSIONAL
ELECTROPHORESIS
R. Wilson, J. Bateman. Murdoch Childrens Research Institute,
Melbourne, AUSTRALIA
Purpose: There is increasing interest in proteomic techniques for global
proﬁling of normal and pathological cartilage samples, to elucidate under-
lying disease mechanisms identify novel biomarkers. Identiﬁcation of pro-
tein expression differences using two-dimensional electrophoresis (2-DE)
and liquid chromatographic (LC)-based proteomics depends critically on
reproducibility throughout sample preparation and analysis. This applies
particularly where sample fractionation is used to remove high abundance
or interfering components to facilitate deeper mining of the proteome.
Here we have developed and validated a procedure for solubility-based
cartilage sample fractionation and reproducible resolution by 2-DE.
Methods: Triplicate independent sequential extractions were performed
on mouse femoral head cartilage. Pulverized explants were digested with
chondroitinase ABC then extracted in Tris acetate containing 1M NaCl
for 24 hrs (E0 fraction). The NaCl-insoluble fraction was then further
extracted for 18 hrs in sodium acetate containing 4M GuHCl (E1 fraction).
Finally, to prepare samples for 2-DE, high molecular weight components
that prohibit isoelectric focusing (hyaluronan and aggrecan) were re-
moved by 100 kDa cut-off centrifugal ﬁltration (E2 fraction). Triplicate E0,
E1 and E2 fractions were ﬁrst proﬁled by SDS-PAGE. E0 and E1 were
then resolved by 2-DE in triplicate to compensate for variation in 2-DE
and silver staining and the 18 gel images were analyzed in ImageMaster.
The E0 and E1 extracts were characterized by identiﬁcation of protein
spots by tandem mass spectrometry (MS).
Results: The 1-D proﬁles of E0, E1 and E2 fractions were highly
consistent between extractions (see ﬁgure). Centrifugal ﬁltration caused
partitioning of some proteins <100 kDa into the E2 fraction but this was
also consistent between samples. E0 and E1 fractions produced distinct
protein 2-DE spot patterns, with greater complexity in E0. Automated
spot analysis reported 70% spot matching in E0 gel triplicates and
75% matching in E1 gel triplicates, representing approximately 600 and
500 matched spots, respectively. E0-speciﬁc spots were mostly cellular
proteins, e.g. BiP, triosephosphate isomerase and gelsolin, whereas E1-
speciﬁc spots were abundant matrix proteins, e.g. collagen VI, matrilins
1 and 3, and lactadherin. Interestingly, some speciﬁc proteins such as
link protein and beta-actin partitioned almost equally between E0 and E1
extracts. MS results were validated by immunoblotting.
Conclusions: This study has, using the minimal amounts of tissue
available from mouse tissue, established a new approach to 2-DE based
analysis of cartilage extracts. This method can be used to enrich one or
both protein fractions for deeper mining of the cartilage proteome and
to investigate cellular mechanisms and matrix components involved in
developmental and degenerative cartilage disease.
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Purpose: To develop proteomics to analyze mouse cartilage degradation
and correlate transcriptional and translational responses to catabolic
stimuli.
Methods: Proteomic techniques were used to analyze catabolism in
mouse femoral head cartilage. Using speciﬁc methods to prepare carti-
lage extracts and conditioned media for two-dimensional polyacrylamide
gel electrophoresis (2-D PAGE) and subsequent tandem mass spectrom-
etry (MS), we identiﬁed novel proteins and fragments released into the
media of control, interleukin-1a (Il-1) and all-trans-retinoic acid (RetA)-
treated explants. Fluorescent difference gel electrophoresis (2-D DIGE)
was used to quantify protein expression changes. We also measured
changes in mRNA expression to distinguish transcriptional and post-
translational regulation of released proteins.
Results: We identiﬁed 20 differentially-abundant proteins in media from
control and treated explants, including fragments of thrombospondin-1
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and connective tissue growth factor. Il-1 stimulated release of the cartilage
degeneration marker MMP-3, as well as proteins with uncharacterized
roles in cartilage pathology, such as neutrophil gelatinase-associated
lipocalin. RetA stimulated release of extracellular matrix proteins COMP,
link protein and matrilin-3 into the media, accompanied by dramatic
reduction in corresponding mRNA transcripts levels. Gelsolin, implicated
in cytoskeletal reorganization in arthritic synovial ﬁbroblasts but not pre-
viously associated with cartilage pathology, was regulated by Il-1 and
RetA.
Conclusions: This ﬁrst analysis of mouse cartilage degradation and
protein release using proteomics has identiﬁed proteins and fragments,
some of which represent novel candidate biomarkers for cartilage degra-
dation. Applying these proteomic techniques to wild-type and genetically-
modiﬁed mouse cartilage will provide insights into mechanisms of carti-
lage degeneration.
476 GLUCOSAMINE SULFATE AND CHONDROITIN SULFATE:
THEIR EFFECT ON CHONDROCYTE PROTEOME
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Purpose: Some symptomatic slow-acting drugs, such as glucosamine
sulfate (GS) and chondroitin sulfate (CS), have proved efﬁcacy in relieving
the symptoms of mild and moderate osteoarthritis (OA). In vitro and
in vivo studies have demonstrated that these drugs are capable to inhibit
cartilage destruction and to promote disease suppression. However, their
mechanism of action remains poorly characterized. The aim of this study
was to evaluate the effects of these compounds on cartilage biology, alone
or in combined administration, in normal chondrocytes stimulated with
interleukin-1b (anti-inﬂammatory effect) and in osteoarthritic chondrocytes
(disease modifying effect).
Methods: Chondrocytes were obtained from 3 osteoarthritic patients
undergoing joint replacement and from 3 healthy donors. Normal chon-
drocytes were treated with GS 10mM and/or CS 200 mg/mL, and then
stimulated with Il-1b 10 ng/mL. Osteoarthritic chondrocytes were treated
with GS 10mM and CS 200 mg/mL, alone and in combination. Whole cell
proteins were isolated 24 hours after cellular stimulation and resolved
by two-dimensional electrophoresis (2-DE). The gels were stained with
SYPRORuby and digitized using a CCD camera. The image analysis was
performed using the PDQuest 7.3.1 computer software. Using PDQuest
tools, protein spots were enumerated, quantiﬁed and characterized with
respect to their molecular mass and isoelectric point by bilinear inter-
polation between landmark features on each image. Protein expression
data from each gel were normalized for the total density present in the gel
images. Differentially abundant proteins were identiﬁed by matrix-assisted
laser desorption/ionization-time of ﬂight mass spectrometry (MALDI-
TOF/TOF).
Results: We examined a mean of 500 protein spots that were present in
each gel. Both qualitative and quantitative changes in protein expression
patterns between controls and treated cells were studied. In normal
chondrocytes, 39 protein forms were modulated by GS treatment, 35 by
CS treatment and 48 by GS+CS treatment compared to the control (cells
stimulated with Il-1b). In osteoarthritic chondrocytes, 11 protein forms
were found to be statistically altered in GS treated cells, 9 in CS treated
cells and 17 in GS+CS treated cells compared to the untreated cells
(p< 0.05). Most of the identiﬁed proteins are involved in stress response
(HSP7C, HSPB1, ANXA2), cellular metabolism (AK1C2, PGK1, KPYM),
protein folding (PDIA1, PDIA3), protein targeting (GRP78) and oxidative
stress (SODM, PRDX1).
Conclusions: This study describes the differences between the pro-
tein proﬁles of normal and osteoarthritic chondrocytes treated with glu-
cosamine and/or chondroitin sulfate. We have identiﬁed novel molecular
targets that might explain the efﬁcacy of these molecules in osteoarthritis
treatment. Our results highlight the synergic effect of the combined admin-
istration and the effectiveness of the two molecules as anti-inﬂammatory
drugs (anti-IL1b effect).
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477 HEY-1 INTERACTS WITH SOX9 TO MEDIATE PASSIVE
REPRESSION OF CHONDROGENESIS
S.P. Grogan, D.C. Brinson, J. Valbracht, M.K. Lotz. The Scripps
Research Institute, La Jolla, CA, USA
Purpose: Notch signaling induces bHLH proteins (Hes-1 and Hey-1) that
actively repress Col2a1 transcription by binding N-box domains located in
intron 1 of Col2a1. bHLH proteins also participate in passive repression
by binding activator proteins. In this current study, we tested whether
Hey-1 directly binds to Sox9 using luciferase reporter and GST-pull down
assays.
Methods: Luciferase Assays. Chondrogenic ATDC5 cells were co-
transfected using FuGENE HD (Roche). The 12x48-pGL3P-Luc luciferase
reporter plasmid that does not contain bHLH binding domains was used.
Readings were normalized by Renilla (pRL-SV40; Promega). Sox9 and
bHLH interaction was tested by over expression using pcDNA-FLAG-
Sox9 in combination with pCMV-FLAG-Hes-1 and pcDNA3-FLAG-Hey-1.
Luciferase activities were analyzed 48 hours following transfection using
the Dual-Luciferase Reporter Assay System (Promega).
GST-pull down assays. Sox9 and Hey-1 interaction was tested using
GST-Hey-1 and 35S-met-Flag-Sox9. GST-Hey-1 and 35S-HA-Hes-1 were
also utilized. The pGEX-Hey-1 expression plasmid was transduced in
BL21 cells (Stratagene), lysed and bound to Glutathione Sepharose (GE
Healthcare). A Reticulocyte system (Promega) was used to produce 35S-
met-labelled proteins (Sox9 and Hes-1). Appropriate combinations of
GST and 35S-met-labelled protein were mixed overnight at 4C. Beads
were extensively washed, placed into SDS loading buffer and loaded on
SDS-page gels (Invitrogen). Dried gels were exposed to ﬁlm for detection
of radioactive signal.
Results: Luciferase assays show that Sox9 increased reporter expres-
sion levels 70-fold relative to control (Fig. 1A). Co-transfection with
Sox9/Hes-1 and Sox9/Hey-1 led to an 81% and 64% reduction in reporter
levels, respectively (Fig. 1A). Detection of a band at 60kDa in the GST
pull down assays indicated that Sox9 and Hey-1 bind (Fig. 1B). Interaction
between Hey-1 and Hes-1 (positive control) was also observed (Fig. 1B).
Figure 1. (A) Luciferase assay showing Sox9 induction of Col2al reporter
and competitive inhibition of reporter signal by Hes-1 and Hey-1. (B) GST-
Pulldown assay demonstrating that Hey-1 and Sox9 proteins (lane 3) and
Hes-1 and Hey-1 proteins (lane 8) interact. (lane 1=20% onput 35S-met-
Sox9; lane 2=GST-Hey beads only; lane 3=GST-Hey beads+35S-met-
Sox9; lane 4=GST-null beads+35S-met-Sox9; lane 5=plain beads+35S-
met-Sox9; lane 6=20% onput 35S-met-HA-Hes; lane 7=GST-null beads
only; lane 8=GST-Hey+35S-met-HA-Hes; lane 9=GST-null beads+35S-
met-HA-Hes; lane 10=plain beads+35S-met-HA-Hes).
Conclusions: These data indicate that Hey-1 passively represses Col2a1
transcription by directly binding to Sox9. Since a reduced luciferase
signal was observed with Hes-1/Sox9 co-transfection, we suggest that
this bHLH also binds to Sox9. We propose that high bHLH levels repress
Col2a1 transcription both actively and passively. The elevated bHLH
milieu leads to passive repression by competitively binding with Sox9.
During chondrogenesis, Notch signaling and bHLH levels are reduced,
which permits a shift away from a repression environment to allow Sox9
to drive transcription.
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